| abstract |
The present invention relates to compounds of formula I (see formula I) in which R1, R2, R3, m and n are as defined; the compounds of formula I have peptide A? production inhibitory activity; The invention also relates to pharmaceutical compositions and methods for treating disorders and diseases, for example, neurodegenerative and / or neurological disorders, for example, Alzheimer's disease, in a mammal, comprising compounds of formula (I). |